政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/124270

政大典藏 > College of Communication > Master`s Program in Communication > Theses > Item 140.119/124270

Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/124270

Title:	《大麻煩不凡？》一個多媒體報導文學試驗 Cannabis in Taiwan: Cure or Conundrum? A Multi-media Reportage
Authors:	孫珞軒 Sun, Lo-Shuan
Contributors:	盧非易孫珞軒 Sun, Lo-Shuan
Keywords:	大麻合法化多媒體報導文學 Cannabis Legalization Multi-media Reportage
Date:	2019
Issue Date:	2019-07-01 11:14:19 (UTC+8)
Abstract:	大麻在人類歷史中並不新鮮，人類自古以來就開始種植大麻並使用大麻。大麻做為一種非常古老的經濟和藥用作物，已存在於人類社會上千年，其韌皮纖維可以用於工業、紡織、造紙甚至建築；其籽可以榨油或做為食物及飼料；其花與葉中含量最高的的大麻素（cannabinoids）具有重要的醫學及休閒用途，被視為是世界上用途最廣且最熟為人知的植物之一。《大麻煩不凡？》這個題目具有多重雙關之意，顧名思義是想探討大麻對於社會的「麻煩之處」為何？或是反過來說，大麻的非法性，會產生那些麻煩？另外也從不同的角度來重新看待這個植物，去探討它的「不凡之處」有哪些。本文分為創作論述及報導主文兩大部分，創作論述包含寫作緣起、文獻探討與主題背景、經典作品分析、創作手法及故事素材。報導主文則分為「大麻議題探討」及「大麻人物誌」兩大面向，奇數篇為「大麻議題探討」部分，皆以「綠」字為題，偶數篇為「大麻人物誌」，皆以「我」字為題。「大麻人物誌」共採訪了四位受訪者，前兩篇以文字呈現，後兩篇以紀錄短片的方式呈現。本報導將「大麻人物誌」的第一人稱敘述故事穿插進「大麻議題探討」各篇主文之間，藉此賦予報導中的生動性及文學性。 Cannabis has a long history in human society, mankind has been growing and using cannabis since 10,000 years ago. Cannabis is an important economic and medicinal plant in human society for thousands of years. Its fiber can be used in industry, textiles, paper and even construction; its seeds can be used for oil, food, and feed; its flowers and leaves contain cannabinoids with important medical and recreational purpose. It can be used as whole-plant and is considered to be one of the most versatile and well-known plants in the world. The topic "Cannabis in Taiwan: Cure or Conundrum?" has multiple meanings. As the topic suggests, this reportage is meant to explore the "cure" and "conundrum" aspects of cannabis in Taiwan society. "Cannabis in Taiwan: Cure or Conundrum?" divided into two parts: the introduction of creation and the main text of the multi-media reportage. The introduction of the creation includes the origin of writing, literature discussion and topic background, analysis of cannabis-related documentaries, books and report, creation techniques and story materials. The main texts of the reportage then divided into two major aspects: "Cannabis Issues" and "Cannabis Characters". The odd-numbered articles are "Cannabis Issues", all of them are titled "Green". The even-numbered articles are "Cannabis Characters", all of them are titled "I". "Cannabis Characters" interviewed four people, the first two were presented with multi-media reports and the last two were presented with short films. The reportage mix the first-person stories of "Cannabis Characters" with the discussion on "Cannabis Issues", thereby giving vividity and literary features to the reportage.
Reference:	中文文獻王亞維譯（2010）。《製作紀錄片》（第二版），台北：遠流。（原書Rabiger[1998]. Directing the Documentary. USA: Butterwort-Heinemann）。王皇玉（2004）。〈論施用毒品行為之犯罪化〉，《台大法學論叢》，33（6）：39-76。王慰慈（2003）。〈台灣紀錄片的類型發展與分析-以Bill Nichols的六種模式為研究基礎〉。《廣播與電視》，20：1-33。申丹、王麗亞（2010）。《西方敘事學：經典與後經典》，北京：北京大學出版社。白錫鏗（2017）。〈監獄一半都是毒品犯政院秘書長：毒品成國安問題〉，《聯合報》。取自 https://udn.com/news/story/7315/2543612 李文吉譯（2004）。《紀實攝影》，台北：遠流。（原書Arthur Rothstein[1986]. Documentary Photography. USA: Focal Press）。李道明（2009）。〈從紀錄片的定義思索紀錄片與劇情片的混血形式〉，《戲劇學刊》，10：79-109。李道明（2015）。《紀錄片：歷史、美學、製作、倫理》，台北：三民。何佳琪、林靜芳、林嬪嬪、陳慧諴（2014）。〈毒物及健康風險〉，《科學月刊》。取自 http://scimonth.blogspot.tw/2014/03/blog-post_8056.html 東方日報（2016）。〈泰國擬合法化大麻〉，《東方日報》。取自 http://www.orientaldaily.com.my/s/158592# 林宛諭（2016）。〈種大麻判4年美國人法庭內自裁身亡〉，《聯合影音網》。取自 https://video.udn.com/news/509241 林翠儀（2016）。〈種大麻治癌被訴日男反控違憲〉，《自由時報》。取自http://news.ltn.com.tw/news/world/paper/982996 林瑋婷（2017）。〈以健康為核心的毒品政策〉，《民間司法改革基金會》。取自https://www.jrf.org.tw/articles/1221。林慧珍譯（2013）。《藥物讓人上癮》，新北：大家。（原書Leigh, Jeremy, Wilkie, Cynthia, & Scott [2008]. Buzzed: the straight facts about the most used and abused drugs from alcohol to ecstasy. NY: W.W. Norton）周慶祥（2009）。《深度報導》，台北：五南。徐世傑（2003）。《靈藥與魔藥》，新北：旺文社。徐沛然譯、Ellen Brown（2016）。〈大麻戰爭（上）以健康之名，除罪化究竟誰得利？〉，《苦勞網》。取自http://www.coolloud.org.tw/node/86245。陳治諶、楊榮季、賴建璋（2009）。〈砒霜的臨床應用〉，《藥學雜誌電子報》。取自 http://jtp.taiwan-pharma.org.tw/101/146-150.html 陳嘉新（2017）。〈處罰與治療：檢視台灣的藥物濫用防制政策〉，《巷仔口社會學》。取自https://twstreetcorner.org/2017/12/12/chenjiashin/。陳嫻若譯（2014）。《不懂設計也能做出令人驚豔的資訊圖表》，新北：聯經。（原書櫻田潤 [2013]. たのしいインフォグラフィック入門.日本: Fビー・エヌ・エヌ新社）。彭家發（1986）。《特寫寫作》，台北：商務印書館。鄭煥昇譯（2018）。《傷風敗俗文化史：十五個改寫人類文明的墮落惡習》，台北：時報。（原書 Robert Evans [2016]. A Brief History of Vice - How Bad Behavior Built Civilization. USA : Plume）。劉玥琳（2017）。〈吸毒自傷行為，究竟招誰惹誰？〉，《鳴人堂》。取自https://opinion.udn.com/opinion/story/10043/2396787。劉得倉（2017）。〈大麻合法化泰國特許6省實驗種植〉，《中央社》。取自http://www.cna.com.tw/news/ahel/201712140322-1.aspx。盧非易（1999）。〈紀錄片的再現觀念與技術之演進〉。《傳播研究簡訊》，14：14-16。戴伸峰（2017）。〈反毒何以返毒？——藥物濫用防治教育的科普觀點〉，《鳴人堂》。取自https://opinion.udn.com/opinion/story/10981/2371424。薛絢譯（2012）。《上癮五百年》，新北：立緒。（原書David T. Courtwright[2001]. Forces of Habit. Cambridge, Mass.: Harvard University Press）。韓耀叢（2001）。〈紀錄片再現真實的再思考〉，「獨立製片與紀錄片國際學術研討會」，台南官田。魏志勝（2013）。〈毒品授權與定義之橫解縱剖〉。國立高雄大學政治法律學系研究所碩士論文。嚴云岑（2017）。〈劉士毅想用「大麻」治妞妞醫舉「猩猩實驗」態度保留〉，《ETtoday健康雲》。取自 https://health.ettoday.net/news/1002864 外文文獻 Abel, E. (1980). Marihuana: The First Twelve Thousand Years. New York, NY:Springer. Andrews, M. (Producer), & Spirer, P. (Director). (2017). The Legend of 420[Documentary]. United States: Head Gear Films. Bachhuber, M., Saloner, B., Cunningham, C., & Barry, C. (2014). Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), p.1668. Baum, Dan. (2016). Legalize It All. Harper’s Magazine. Retrieved form https://harpers.org/archive/2016/04/legalize-it-all/ Bobroff, M., Metz, D. (Producer), & Harvey, B. (Director). (2014). The Culture High[Documentary]. United States: Score G Production Films. Devinsky, O., Cilio, M., Cross, H., Fernandez-Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras-Aswad, D., Notcutt, W., Martinez-Orgado, J., Robson, P.,Rohrback, B., Thiele, E., Whalley, B., & Friedman, D. (2014). Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), pp.791-802. Doré, Louis. (2017). The legality of weed in countries around the world,Mapped. Independent. Retrieved form https://www.indy100.com/article/where-is-marijuana-legal-drug-laws-map-weed-cannabis-hash-possession-prison-time- 8118461 Félix, S., & Portugal, P. (2017). Drug Decriminalization and the Price of Illicit Drugs. International Journal of Drug Policy 39: 121-129. Fuller, Thomas. (2016). Voters Legalize Marijuana in Three States. The New York Times. Retrieved form https://www.nytimes.com/2016/11/09/us/politics/election-ballot.html Gable, R. (2006). The Toxicity of Recreational Drugs. American Scientist, 94(3),p.206. Gaviria, César. (2017). President Duterte Is Repeating My Mistakes. The New York Times. Retrieved form https://www.nytimes.com/2017/02/07/opinion/president-duterte-is-repeating-my-mistakes.html Gillings, A. (Executive Producer). (2013). Cannabis: The Evil Weed?/ Horizon[Television broadcast]. United Kingdom: BBC. Global Commission on Drug Policy. (2011). Report of the Global Commission On Drug Policy, Retrieved form https://www.globalcommissionondrugs.org/wp-content/themes/gcdp_v1/pdf/Global_Commission_Report_English.pdf Gupta, S. (Executive Producer). (2013). Weed/ Sanjay Gupta MD Special Report[Television broadcast]. United States: CNN. Hall, W., Room, R., & Bondy S. (1995). A Comparative Appraisal of the Health andPsychological Consequences of Alcohol, Cannabis, Nicotine and Opiate Use.Retrieved from http://www.academia.edu/2868073/A_comparative_appraisal_ of_the_health_and_psychological_consequences_of_alcohol_cannabis_nicotine_and_opiate_use Herb. (2015). Where Did We Go Wrong: A Very Brief History of Cannabis,Retrieved form https://herb.co/2015/04/16/where-did-we-go-wrong-a-very-brief-history-of-cannabis/ Hughes, C., & Stevens, A. (2010). What Can We Learn from the Portuguese Decriminalization of Illicit Drugs? British Journal of Criminology 50: 999-1022 Joy, J., Watson, S., & Benson, J. (Eds.). (1999). Marijuana and medicine, assessing the science base. Washington, DC: National Academy Press. Lucas, P., & Walsh, Z. (2017). Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy, 42, pp.30-35. McKay, Tom. (2015). These 3 Drugs Are Much Deadlier Than Marijuana, but They`re All Totally Legal. Mic. Retrieved form https://mic.com/articles/109718/these-3-drugs-are-much-deadlier-than-marijuana-but-they-re-all-totally- legal-.JD9j5t0nj Meier, M., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R., McDonald,K., Ward, A., Poulton, R., & Moffitt, T. (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences, 109(40), pp.E2657-E2664. Morgan, C., Das, R., Joye, A., Curran, H., & Kamboj, S. (2013). Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings. Addictive Behaviors, 38(9), pp.2433-2436. The National Academies of Sciences, Engineering, Medicine. (2017). The Health Effects of Cannabis and Cannabinoids. Washington, DC: The National Academies Press. Nutt, D., King, L., & Phillips, L. (2010). Drug harms in the UK: a multicriteria decision analysis. The Lancet, 376(9752), pp.1558-1565. Pagano, Alyssa. (2018). The racist origins of marijuana prohibition. Business Insider. Retrieved form http://www.businessinsider.com/racist-origins-marijuana- prohibition-legalization-2018-2 Piper, B., DeKeuster, R., Beals, M., Cobb, C., Burchman, C., Perkinson, L., Lynn, S.,Nichols, S., & Abess, A. (2017). Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. Journal of Psychopharmacology, 31(5), pp.569-575. Pletcher, M., Vittinghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., Lin, F.,& Kertesz, S. (2012). Association Between Marijuana Exposure and Pulmonary Function Over 20 Years. JAMA, 307(2), p.173. Power, R., Verweij, K., Zuhair, M., Montgomery, G., Henders, A., Heath, A.,Madden, P., Medland, S., Wray, N., & Martin, N. (2014). Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular Psychiatry, 19(11), pp.1201-1204. Proal, A., Fleming, J., Galvez-Buccollini, J., & DeLisi, L. (2014). A controlled family study of cannabis users with and without psychosis. Schizophrenia Research, 152(1), pp.283-288. Robinson, R. (1995). The great book of hemp. Rochester, Vt: Park Street Press. Sides, Hampton. (2015). Science Seeks to Unlock Marijuana Secrets. National Geographic. Retrieved form https://www.nationalgeographic.com/magazine/2015/06/marijuana-science-drug-research-legality/ Socías, M., Kerr, T., Wood, E., Dong, H., Lake, S., Hayashi, K., DeBeck, K., Jutras-Aswad, D., Montaner, J., & Milloy, M. (2017). Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. Addictive Behaviors, 72, pp.138-143. Steinmetz, Katy. (2016.). These States Just Legalized Marijuana. Time. Retrieved form http://time.com/4559278/marijuana-election-results-2016/ Subbaraman, M. (2014). Can Cannabis be Considered a Substitute Medication for Alcohol?. Alcohol and Alcoholism, 49(3), pp.292-298. Timmons, Heather. (2014). China is cornering the cannabis patent market. Quartz. Retrieved form https://qz.com/163726/china-is-cornering-the-cannabis-patent-market/ U.S. Bureau of Economic Analysis. (2018). Personal consumption expenditures:Nondurable goods: Alcoholic beverages purchased for off premises consumption, Retrieved form https://fred.stlouisfed.org/series/DAOPRC1A027NBEA U.S. Bureau of Economic Analysis. (2018). Personal consumption expenditures:Nondurable goods: Tobacco, Retrieved form https://fred.stlouisfed.org/series/DTOBRC1A027NBEA U.S. Department of Justice, Drug Enforcement Administration. (2017). Drugs of Abuse: A DEA Resource Guide (DOJ & DEA Publication). Retrieved from https://www.dea.gov/pr/multimedia-library/publications/drug_of_abuse.pdf Volkow, N., Baler, R., Compton, W., & Weiss, S. (2014). Adverse Health Effects of Marijuana Use. New England Journal of Medicine, 370(23), pp.2219-2227. World Health Organization Expert Committee on Drug Dependence. (2017). Cannabidiol (CBD) Pre-Review Report Agenda Item 5.2, Retrieved form http://www.who.int/medicines/access/controlled-substances/5.2_CBD.pdf 報導引用文獻 Abel, E. L. (1980). Marihuana: The first twelve thousand years. New York: Springer Science Business Media, LLC. Abuhasira, R., Schleider, L. B., Mechoulam, R., & Novack, V. (2018). Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine,49, 44-50. Allen, R. W., Jex, H. R., Mcruer, D. T., & Dimarco, R. J. (1975). Alcohol Effects on Driving Behavior and Performance in a Car Simulator. IEEE Transactions on Systems, Man, and Cybernetics,SMC-5(5), 498-505. Aran, A., Cassuto, H., Lubotzky, A., Wattad, N., & Hazan, E. (2018). Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems—A Retrospective Feasibility Study. Journal of Autism and Developmental Disorders,49(3), 1284-1288. Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. Bmj,344(Feb09 2). Atakan, Z. (2012). Cannabis, a complex plant: Different compounds and different effects on individuals. Therapeutic Advances in Psychopharmacology,2(6), 241-254. Aydelotte, J. D., Brown, L. H., Luftman, K. M., Mardock, A. L., Teixeira, P. G., Coopwood, B., & Brown, C. V. (2017). Crash Fatality Rates After Recreational Marijuana Legalization in Washington and Colorado. American Journal of Public Health,107(8), 1329-1331. Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010. JAMA Internal Medicine,174(10), 1668. Barry, A. E., King, J., Sears, C., Harville, C., Bondoc, I., & Joseph, K. (2015). Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use. Journal of School Health,86(1), 31-38. Bergamaschi, M. M., Queiroz, R. H., Chagas, M. H., Oliveira, D. C., Martinis, B. S., Kapczinski, F., . . . Crippa, J. A. (2011). Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients. Neuropsychopharmacology,36(6), 1219-1226. Bhattacharyya, S., Wilson, R., Appiah-Kusi, E., O’Neill, A., Brammer, M., Perez, J., . . . Mcguire, P. (2018). Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis. JAMA Psychiatry,75(11), 1107. Bifulco, M., Laezza, C., Pisanti, S., & Gazzerro, P. (2006). Cannabinoids and cancer: Pros and cons of an antitumour strategy. British Journal of Pharmacology,148(2), 123-135. Birch, E. (1889). The Use Of Indian Hemp In The Treatment Of Chronic Chloral And Chronic Opium Poisoning. The Lancet,133(3422), 625. Blanco, C., Hasin, D. S., Wall, M. M., Flórez-Salamanca, L., Hoertel, N., Wang, S., . . . Olfson, M. (2016). Cannabis Use and Risk of Psychiatric Disorders. JAMA Psychiatry,73(4), 388. Bosker, W. M., Theunissen, E. L., Conen, S., Kuypers, K. P., Jeffery, W. K., Walls, H. C., . . . Ramaekers, J. G. (2012). A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid. Psychopharmacology,223(4), 439-446. Bostwick, J. M. (2012). Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana. Mayo Clinic Proceedings,87(2), 172-186. Bradford, A. C., Bradford, W. D., Abraham, A., & Adams, G. B. (2018). Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. JAMA Internal Medicine,178(5), 667. Caspi, A., Moffitt, T. E., Cannon, M., Mcclay, J., Murray, R., Harrington, H., . . . Craig, I. W. (2005). Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction. Biological Psychiatry,57(10), 1117-1127. Ceprián, M., Jiménez-Sánchez, L., Vargas, C., Barata, L., Hind, W., & Martínez-Orgado, J. (2017). Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke. Neuropharmacology,116, 151-159. Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & Elsohly, M. A. (2019). New trends in cannabis potency in USA and Europe during the last decade (2008–2017). European Archives of Psychiatry and Clinical Neuroscience,269(1), 5-15. Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J., & Parsons, L. H. (2016). Keep off the grass? Cannabis, cognition and addiction. Nature Reviews Neuroscience,17(5), 293-306. Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., . . . Wright, S. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. New England Journal of Medicine,376(21), 2011-2020. Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., . . . Zuberi, S. M. (2018). Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome. New England Journal of Medicine,378(20), 1888-1897. Duvall, C. (2015). Cannabis. London: Reaktion Books. Earleywine, M., & Barnwell, S. (2007). Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal,4(1), 11. Earleywine, M. (2005). Understanding marijuana: A new look at the scientific evidence. New York: Oxford University Press. Elvik, R. (2013). Risk of road accident associated with the use of drugs: A systematic review and meta-analysis of evidence from epidemiological studies. Accident Analysis & Prevention,60, 254-267. Evanoff, A. B., Quan, T., Dufault, C., Awad, M., & Bierut, L. J. (2017). Physicians-in-training are not prepared to prescribe medical marijuana. Drug and Alcohol Dependence,180, 151-155. Forti, M. D., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., . . . Murray, R. M. (2012). Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users. Biological Psychiatry,72(10), 811-816. Forti, M. D., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., . . . Ven, E. V. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. The Lancet Psychiatry,6(5), 427-436. Fuss, J., Steinle, J., Bindila, L., Auer, M. K., Kirchherr, H., Lutz, B., & Gass, P. (2015). A runner’s high depends on cannabinoid receptors in mice. Proceedings of the National Academy of Sciences,112(42), 13105-13108. Gable, R. (2006). The Toxicity of Recreational Drugs. American Scientist,94(3), 206. Gamble, L., Boesch, J. M., Frye, C. W., Schwark, W. S., Mann, S., Wolfe, L., . . . Wakshlag, J. J. (2018). Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Frontiers in Veterinary Science,5. Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., . . . Mayo, N. (2019). Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood. JAMA Psychiatry,76(4), 426. Habib, A. M., Okorokov, A. L., Hill, M. N., Bras, J. T., Lee, M., Li, S., . . . Cox, J. J. (2019). Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity. British Journal of Anaesthesia. Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998). Cannabidiol and (-) 9-tetrahydrocannabinol are neuroprotective antioxidants. Proceedings of the National Academy of Sciences,95(14), 8268-8273. Hartman, R. L., & Huestis, M. A. (2012). Cannabis Effects on Driving Skills. Clinical Chemistry,59(3), 478-492. Hazekamp, A., Ware, M. A., Muller-Vahl, K. R., Abrams, D., & Grotenhermen, F. (2013). The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms. Journal of Psychoactive Drugs,45(3), 199-210. Heyman, E., Gamelin, F., Goekint, M., Piscitelli, F., Roelands, B., Leclair, E., . . . Meeusen, R. (2012). Intense exercise increases circulating endocannabinoid and BDNF levels in humans—Possible implications for reward and depression. Psychoneuroendocrinology,37(6), 844-851. Hindocha, C., Freeman, T. P., Grabski, M., Stroud, J. B., Crudgington, H., Davies, A. C., . . . Curran, H. V. (2018). Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction,113(9), 1696-1705. Kandel, D. (1975). Stages in adolescent involvement in drug use. Science,190(4217), 912-914. Keyes, K. M., Brady, J. E., & Li, G. (2015). Effects of minimum legal drinking age on alcohol and marijuana use: Evidence from toxicological testing data for fatally injured drivers aged 16 to 25 years. Injury Epidemiology,2(1). Kirby, T., & Barry, A. E. (2012). Alcohol as a Gateway Drug: A Study of US 12th Graders. Journal of School Health,82(8), 371-379. Lachenmeier, D. W., & Rehm, J. (2015). Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Scientific Reports,5(1). Lee, J. L., Bertoglio, L. J., Guimarães, F. S., & Stevenson, C. W. (2017). Cannabidiol regulation of emotion and emotional memory processing: Relevance for treating anxiety-related and substance abuse disorders. British Journal of Pharmacology,174(19), 3242-3256. Leung, J., Chiu, C. Y., Stjepanović, D., & Hall, W. (2018). Has the Legalisation of Medical and Recreational Cannabis Use in the USA Affected the Prevalence of Cannabis Use and Cannabis Use Disorders? Current Addiction Reports,5(4), 403-417. Levine, J. (1944). Origin of Cannabinol. Journal of the American Chemical Society,66(11), 1868-1870. Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., . . . Koethe, D. (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry,2(3). Li, H. (1973). An archaeological and historical account of cannabis in China. Economic Botany,28(4), 437-448. doi:10.1007/bf02862859 Li, H. (1974). The origin and use of cannabis in eastern asia linguistic-cultural implications. Economic Botany, 28(3), 293-301. doi:10.1007/bf02861426 Linge, R., Jiménez-Sánchez, L., Campa, L., Pilar-Cuéllar, F., Vidal, R., Pazos, A., . . . Díaz, Á. (2016). Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors. Neuropharmacology,103, 16-26. Lucas, P., & Walsh, Z. (2017). Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy,42, 30-35. Mcguire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., . . . Wright, S. (2018). Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. American Journal of Psychiatry,175(3), 225-231. Mcpartland, J., Marzo, V. D., Petrocellis, L. D., Mercer, A., & Glass, M. (2001). Cannabinoid receptors are absent in insects. The Journal of Comparative Neurology,436(4), 423-429. Mcpartland, J. M., & Pruitt, P. (2002). Sourcing the Code. Journal of Cannabis Therapeutics,2(1), 73-103. Mechoulam, R., & Parker, L. A. (2013). The Endocannabinoid System and the Brain. Annual Review of Psychology,64(1), 21-47. Monte, A. A., Shelton, S. K., Mills, E., Saben, J., Hopkinson, A., Sonn, B., . . . Abbott, D. (2019). Acute Illness Associated With Cannabis Use, by Route of Exposure. Annals of Internal Medicine,170(8), 531. Morgan, C. J., Das, R. K., Joye, A., Curran, H. V., & Kamboj, S. K. (2013). Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings. Addictive Behaviors,38(9), 2433-2436. Mounessa, J. S., Siegel, J. A., Dunnick, C. A., & Dellavalle, R. P. (2017). The role of cannabinoids in dermatology. Journal of the American Academy of Dermatology,77(1), 188-190. Nassan, F. L., Arvizu, M., Mínguez-Alarcón, L., Williams, P. L., Attaman, J., Petrozza, J., . . . Keller, M. G. (2019). Marijuana smoking and markers of testicular function among men from a fertility centre. Human Reproduction,34(4), 715-723. Nathan, D. L., Clark, H. W., & Elders, J. (2017). The Physicians’ Case for Marijuana Legalization. American Journal of Public Health,107(11), 1746-1747. Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet,376(9752), 1558-1565. Pacher, P., & Kunos, G. (2013). Modulating the endocannabinoid system in human health and disease - successes and failures. FEBS Journal,280(9), 1918-1943. Pain, S. (2015). A potted history. Nature, 525(7570). doi:10.1038/525s10a Pamplona, F. A., Silva, L. R., & Coan, A. C. (2018). Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. Frontiers in Neurology,9. Payne, K. S., Mazur, D. J., Hotaling, J. M., & Pastuszak, A. W. (2019). Cannabis and Male Fertility: A Systematic Review. Journal of Urology. Piper, B. J., Dekeuster, R. M., Beals, M. L., Cobb, C. M., Burchman, C. A., Perkinson, L., . . . Abess, A. T. (2017). Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. Journal of Psychopharmacology,31(5), 569-575. Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., . . . Bifulco, M. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacology & Therapeutics,175, 133-150. Pletcher, M. J., Vittinghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., . . . Kertesz, S. (2012). Association Between Marijuana Exposure and Pulmonary Function Over 20 Years. Jama,307(2), 173. Power, R. A., Verweij, K. J., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., . . . Martin, N. G. (2014). Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular Psychiatry,19(11), 1201-1204. Proal, A. C., Fleming, J., Galvez-Buccollini, J. A., & Delisi, L. E. (2014). A controlled family study of cannabis users with and without psychosis. Schizophrenia Research,152(1), 283-288. Prudhomme, M., Cata, R., & Jutras-Aswad, D. (2015). Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence. Substance Abuse: Research and Treatment,9. Rogeberg, O., & Elvik, R. (2016). The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction,111(8), 1348-1359. Russo, E. B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology,163(7), 1344-1364. Ryan, S. A., Ammerman, S. D., & O’Connor, M. E. (2018). Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes. Pediatrics,142(3). Schleider, L. B., Mechoulam, R., Lederman, V., Hilou, M., Lencovsky, O., Betzalel, O., . . . Novack, V. (2018). Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. European Journal of Internal Medicine,49, 37-43. Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F., Moore, T. M., & Gur, R. C. (2018). Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults. JAMA Psychiatry,75(6), 585. Sidney, S., Beck, J. E., Tekawa, I. S., Quesenberry, C. P., & Friedman, G. D. (1997). Marijuana use and mortality. American Journal of Public Health,87(4), 585-590. Socías, M. E., Kerr, T., Wood, E., Dong, H., Lake, S., Hayashi, K., . . . Milloy, M. (2017). Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. Addictive Behaviors,72, 138-143. Staples, J. A., & Redelmeier, D. A. (2018). The April 20 Cannabis Celebration and Fatal Traffic Crashes in the United States. JAMA Internal Medicine,178(4), 569. Stevens, A. (2019). Is policy ‘liberalization’ associated with higher odds of adolescent cannabis use? A re-analysis of data from 38 countries. International Journal of Drug Policy,66, 94-99. Subbaraman, M. S. (2014). Can Cannabis be Considered a Substitute Medication for Alcohol? Alcohol and Alcoholism,49(3), 292-298. Tashkin, D. P. (2013). Effects of Marijuana Smoking on the Lung. Annals of the American Thoracic Society,10(3), 239-247. The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. (2017). Washington, DC: The National Academies Press. The Toxicity of Recreational Drugs » American Scientist. (n.d.). Retrieved from https://www.americanscientist.org/issues/pub/the-toxicity-of-recreational-drugs Tomaso, E. D., Beltramo, M., & Piomelli, D. (1996). Brain cannabinoids in chocolate. Nature,382(6593), 677-678. Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse Health Effects of Marijuana Use. New England Journal of Medicine,370(23), 2219-2227. Wall, M. B., Pope, R., Freeman, T. P., Kowalczyk, O. S., Demetriou, L., Mokrysz, C., . . . Curran, H. V. (2019). Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity. Journal of Psychopharmacology,026988111984156. Whiting, P. F., Wolff, R. F., Deshpande, S., Nisio, M. D., Duffy, S., Hernandez, A. V., . . . Kleijnen, J. (2015). Cannabinoids for Medical Use. Jama,313(24), 2456. Zhang, H., Xie, M., Archibald, S. D., Jackson, B. S., & Gupta, M. K. (2018). Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer. JAMA Otolaryngology–Head & Neck Surgery,144(11), 1017.
Description:	碩士國立政治大學傳播學院傳播碩士學位學程 104464043
Source URI:	http://thesis.lib.nccu.edu.tw/record/#G0104464043
Data Type:	thesis
DOI:	10.6814/NCCU201900095
Appears in Collections:	[Master`s Program in Communication] Theses

Files in This Item:

There are no files associated with this item.

社群 sharing

Loading...